The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Not worthy of RNS. If Investor Hub is all the news N4P have to offer, it shows how little progress has been made in commercialising one deal with a Pharma Co. He promised many of us LTH a lot. Delivered an Investor Hub. Disappointed and I will not be engaging on it. BUY SHARES NIGEL
I was invested in Oxford Pharmascience, which Nigel was CEO of. He might well pull a rabbit out of the hat for N4P shareholders. Who knows? All I have seen with N4P is a repeat of what happened with Oxford Pharmascience. Lots of hype but a gradual decline in the share price. N4P has gone from over 25p in June 2018 to sub 1 p today. I hope he delivers this time around.
Well this at least implies we will soon have more to talk about.
Can't be a bad thing,.
Basel that is no big deal. Plenty of small pharmas do not work out.
I was invested in Oxford Pharmascience, which NT, was CEO of. Nigel might pull a rabbit out of the hat for N4P shareholders. Who knows? All I have seen with
the oxford pharmascience story was not good for investors. it delisted. dyor. see additional info on nigel theobald at comapnies house:
https://find-and-update.company-information.service.gov.uk/officers/kadq_ai0k2yz7vv6mpamnn9xhd0/appointments
https://find-and-update.company-information.service.gov.uk/company/06498279/officers
https://find-and-update.company-information.service.gov.uk/officers/dzlfkzuewhlsgqsex8yynyex1dy/appointments
https://*********************/newsfeed/article/proposed-acquisition-and-capital-raising-671971
Does Nigel ever read this board.
He and his directors should buy shares.
Never believe a CEO who states multiple opportunities, provide one result and prove the value for investors. Rarely have I seen a early stage Bio with so little progress and so little news. After many top ups to average down, am still -80% Could be final RNS in next month which causes me to sell and take a huge loss. No disrespect to anyone on here as it had so much promise and SIRNA will one day be a success. We were just too early. I have a few other early stage Bio's and can see CIZ producing an early Lung cancer detection test in US next year. CRUK was slating the UK for being mid table in Europe on cancer survival rates. Early diagnosis is key to good outcome and survival. Denmark way ahead. Wishing all a better 2024.
I think you will find this interesting about Nigel Theobald's previous AIM listed plc. See below from 27 Feb 2013
Nigel Theobald, CEO, commented:
"The Company has made strong progress over the past two years in developing and commercialising its innovative technology platforms and recently raised GBP2 million to strengthen its position for continuing this effort.
We are delighted to have Invesco on board as a major shareholder. This new placement will raise additional funds to allow us to accelerate our work on commercialising our technology platforms and to strengthen our IP position by developing our own dossiers for a range of NSAIDs which we will seek to license to major pharmaceutical companies"
Defined terms are appended to this announcement and have the same meaning as the Circular. The letter from the Chairman to be contained in the Circular is repeated below without material adjustment.
For further information please contact:
Oxford Pharmascience Group plc
Nigel Theobald, Chief Executive +44 1865 854 874
Sound familiar to N4P RNS' doesn't it? Well, in a nutshell it didn't end too well in the end for private investors. DYOR.
220 days since the last sirns update !!! ridiculous to be honest !!
this is finished, there carnt be no good news !!!
the share price is lowest its eva been , there been no update !!!
i thought nigel was genuie when i first started investing in this company !!! 3 years later its a complete load of *******s.!!! down thousands, have a loverly xmas nigel on all our money !!!!@
I'm in the same situation.
Very upbeat presentation and then radio silence on everything.
They can't keep placing as 2p was a disaster and now 1p is going the same way.
But it could turn overnight. Just need to get a move on.
I must say i'm not feeling overly confident that we are going to see better days.
i sincerely hope so however the lack of anything being put into the public domain doesn't give me any confidence there is anything of note happening behind the door of N4P.
I'm far too deep in the hole to even consider selling my shares but the idea that this is going to have a happy ending is seeming more and more unrealistic.
fingers crossed I'm wrong. We must be due some form of notification soon.
I see Fusion Antibodies ratcheted up 150% today.
C'mon Nige, get some juicy collaborations done
All the info is in the last very useful and impressive presentation from Paul and Nigel. Nanogenics could be the deal if the century or not. Nigel pointed there out there are options other that direct finance from N4 if required. No more placings at current SP obviously. ‘ the best way to validate N4p is to get product into clinical trial.’ This is what is happening now along with grants for further research with Professor Yu at Queensland uni where it all begins!
Agree Danzal must be getting close to another placing . We will see some kind of activity just before placing, same pattern over the last few years .
Suddenly seems to be a lot of interest.
we're all long enough in the tooth to not get too excited but nice to see some positive purchases dropping in
Probably another placing 🤣
When I bought this share I was a young man with hair, It's like a life sentence with no parol.
Will be next Pharma to go crazy imo
Is going on with the SP. Nige?
We own two companies, but haven't received any operational updates via RNS since April. I was expecting the company to change after the acquisition and the presentation but it has got worse. Dreadful CEO.
Tempest Therapeutics gained 3,973% last month so there is hope for N4P. It's interesting to note that Tempest had a similar share price implosion to N4P's which saw it fall to approx $1 US dollar before results from its liver cancer trial were unveiled. Interestingly their MCAP had collapsed similarly to N4P's at $3 million. It then rose from $3 million to $130 million last month. Come on Nigel, we would like a x39 gain for N4P rather than what you've delivered so far: 30p to 1p is a shocking performance....
Good luck, Brighty
Nigel, if you would soon like to release something remotely positive to make use of the current AIM tailwinds, please do not let us stop you.
Lowest share price in the history of N4 !!!!! What is going on ???
I didn't see this going any lower. Come on Nigel pull your finger out.